Todd Machemer

1.5k total citations
28 papers, 1.1k citations indexed

About

Todd Machemer is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Todd Machemer has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Todd Machemer's work include Virus-based gene therapy research (14 papers), Cancer Research and Treatments (7 papers) and RNA Interference and Gene Delivery (6 papers). Todd Machemer is often cited by papers focused on Virus-based gene therapy research (14 papers), Cancer Research and Treatments (7 papers) and RNA Interference and Gene Delivery (6 papers). Todd Machemer collaborates with scholars based in United States, Netherlands and Germany. Todd Machemer's co-authors include Heidrun Engler, Shu-Fen Wen, Daniel C. Maneval, Erlinda Quijano, Thomas Schluep, Sebastien A. Burel, Nathalie C. Bellocq, Scott P. Henry, Suzie H. Pun and Aijie Liu and has published in prestigious journals such as Nucleic Acids Research, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Todd Machemer

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd Machemer United States	18	751	358	221	135	121	28	1.1k
Pauliina Lehtolainen Finland	13	655 0.9×	445 1.2×	232 1.0×	99 0.7×	87 0.7×	16	976
S G Zimmer United States	18	834 1.1×	187 0.5×	232 1.0×	78 0.6×	192 1.6×	38	1.3k
Mai Johnson United States	15	700 0.9×	447 1.2×	318 1.4×	127 0.9×	321 2.7×	22	1.2k
Ángel M. Cuesta Spain	20	631 0.8×	108 0.3×	292 1.3×	107 0.8×	128 1.1×	39	1.1k
Scott Estes United States	16	1.2k 1.5×	275 0.8×	355 1.6×	116 0.9×	168 1.4×	29	1.5k
Toivo Maimets Estonia	17	717 1.0×	118 0.3×	373 1.7×	79 0.6×	85 0.7×	51	1.0k
Cynthia Bedell United States	10	451 0.6×	191 0.5×	253 1.1×	121 0.9×	76 0.6×	11	739
Yingming Li United States	11	801 1.1×	765 2.1×	487 2.2×	163 1.2×	76 0.6×	22	1.2k
Zhenguo Cheng China	19	458 0.6×	259 0.7×	405 1.8×	138 1.0×	181 1.5×	40	929
Patrice Yeh France	21	1.1k 1.5×	750 2.1×	371 1.7×	176 1.3×	109 0.9×	25	1.6k

Countries citing papers authored by Todd Machemer

Since Specialization

Citations

This map shows the geographic impact of Todd Machemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Machemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Machemer more than expected).

Fields of papers citing papers by Todd Machemer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Machemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Machemer. The network helps show where Todd Machemer may publish in the future.

Co-authorship network of co-authors of Todd Machemer

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Machemer. A scholar is included among the top collaborators of Todd Machemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Machemer. Todd Machemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burel, Sebastien A., Todd Machemer, Brenda F. Baker, et al.. (2022). Early-Stage Identification and Avoidance of Antisense Oligonucleotides Causing Species-Specific Inflammatory Responses in Human Volunteer Peripheral Blood Mononuclear Cells. Nucleic Acid Therapeutics. 32(6). 457–472. 14 indexed citations

Machemer, Todd, et al.. (2022). Inflammatory Non-CpG Antisense Oligonucleotides Are Signaling Through TLR9 in Human Burkitt Lymphoma B Bjab Cells. Nucleic Acid Therapeutics. 32(6). 473–485. 12 indexed citations

Curtis, Brian R., Lijiang Shen, Eugene Schneider, et al.. (2020). Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia. Nucleic Acid Therapeutics. 30(2). 94–103. 26 indexed citations

Viney, Nicholas J., Shuling Guo, Bruce L. Tai, et al.. (2020). Ligand Conjugated Antisense Oligonucleotide for the Treatment of Transthyretin Amyloidosis: Preclinical and Phase 1 Data. ESC Heart Failure. 8(1). 652–661. 65 indexed citations

Soriano, Armand, Lawrence Bai, Todd Machemer, et al.. (2017). The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides. Nucleic Acid Therapeutics. 27(5). 272–284. 21 indexed citations

Shen, Lijiang, Gene Hung, Rie Kikkawa, et al.. (2016). Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2′- O -Methoxyethyl Modified Antisense Oligonucleotide. Nucleic Acid Therapeutics. 26(4). 236–249. 18 indexed citations

Burel, Sebastien A., Christopher E. Hart, Todd Machemer, et al.. (2015). Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. Nucleic Acids Research. 44(5). 2093–2109. 148 indexed citations

Burel, Sebastien A., Todd Machemer, Hiroki Kato, et al.. (2012). Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response. Journal of Pharmacology and Experimental Therapeutics. 342(1). 150–162. 25 indexed citations

Pande, Kalyan, Roanna Ueda, Todd Machemer, et al.. (2009). Cancer-induced Expansion and Activation of CD11b+Gr-1+ Cells Predispose Mice to Adenoviral-triggered Anaphylactoid-type Reactions. Molecular Therapy. 17(3). 508–515. 18 indexed citations

10.

Machemer, Todd, Heidrun Engler, Van Tsai, et al.. (2005). Characterization of Hemodynamic Events Following Intravascular Infusion of Recombinant Adenovirus Reveals Possible Solutions for Mitigating Cardiovascular Responses. Molecular Therapy. 12(2). 254–263. 13 indexed citations

11.

Connor, Robert, Jennifer M. Anderson, Todd Machemer, Daniel C. Maneval, & Heidrun Engler. (2005). Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: A study in rats evaluating dosing regimens. Urology. 66(1). 224–229. 33 indexed citations

12.

Engler, Heidrun, Todd Machemer, Jennifer Philopena, et al.. (2004). Acute hepatotoxicity of oncolytic adenoviruses in mouse models is associated with expression of wild-type E1a and induction of TNF-α. Virology. 328(1). 52–61. 44 indexed citations

13.

Engler, Heidrun, Todd Machemer, Thomas Schluep, et al.. (2003). Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice. Molecular Therapy. 7(4). 558–564. 10 indexed citations

14.

Demers, G W, et al.. (2002). Tumor Growth Inhibition by Interferon-α using PEGylated Protein or Adenovirus Gene Transfer with Constitutive or Regulated Expression. Molecular Therapy. 6(1). 50–56. 4 indexed citations

15.

Engler, H, Todd Machemer, Suganto Sutjipto, et al.. (2001). Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium. Gene Therapy. 8(1). 41–48. 39 indexed citations

16.

Ahmed, C. M. Iqbal, Duane E. Johnson, G W Demers, et al.. (2001). Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers. Cancer Gene Therapy. 8(10). 788–795. 33 indexed citations

17.

Engler, Heidrun, Scott C. Anderson, Todd Machemer, et al.. (1999). Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents. Urology. 53(5). 1049–1053. 41 indexed citations

18.

Harris, Matthew P., Scott C. Anderson, Todd Machemer, et al.. (1996). Adenovirus-mediatedp53 gene transfer suppresses growth of human glioblastoma cellsin vitro andin vivo. International Journal of Cancer. 67(6). 808–815. 80 indexed citations

19.

Anderson, Scott C., Todd Machemer, Suganto Sutjipto, et al.. (1996). Adenovirus‐mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. International Journal of Cancer. 67(6). 808–815. 6 indexed citations

20.

Machemer, Todd, et al.. (1995). Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110RB, the retinoblastoma tumor suppressor protein.. PubMed. 10(4). 697–704. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact